Inhibition of voltage-sensitive sodium channels in neuroblastoma cells by antiarrhythmic drugs.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001496:Batrachotoxins / Q000378:metabolism; D001667:Binding, Competitive; D002478:Cells, Cultured; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects*; D008564:Membrane Potentials / Q000187:drug effects; D009447:Neuroblastoma; D011485:Protein Binding / Q000187:drug effects; D012530:Saxitoxin / Q000378:metabolism; D012604:Scorpion Venoms / Q000378:metabolism; D012964:Sodium / Q000378:metabolism*
D000889:Anti-Arrhythmia Agents; D001496:Batrachotoxins; D007473:Ion Channels; D012604:Scorpion Venoms; D012530:Saxitoxin; D012964:Sodium